Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Xi Cheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0009-8189; OpenAlex author ID A5100747633. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2016: 2 papers · 2017: none · 2018: 1 paper · 2019: 1 paper

Papers 4

  1. INPP4B As A Prognostic And Diagnostic Marker Regulates Cell Growth Of Pancreatic Cancer Via Activating AKT. Co-author DOI 10.2147/ott.s223221↗
  2. CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species. First author DOI 10.1002/1878-0261.12179↗
  3. Pseudomonas aeruginosa-mannose-sensitive hemagglutinin inhibits pancreatic cancer cell proliferation and induces apoptosis via the EGFR pathway and caspase sig… Co-author DOI 10.18632/oncotarget.12844↗
  4. Leukemia inhibitory factor receptor negatively regulates the metastasis of pancreatic cancer cells in vitro and in vivo. Co-author DOI 10.3892/or.2016.4865↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chenghong Peng · 3 shared papers, 2016–2018 · strength 0.19
  2. Weihua Qiu · 3 shared papers, 2016–2018 · strength 0.19
  3. Baiyong Shen · 3 shared papers, 2016–2018 · strength 0.19
  4. Zhiping Fu · 2 shared papers, 2016–2018 · strength 0.13
  5. Ding Ma Ma · 2 shared papers, 2016 · strength 0.12
  6. Hao Qian · 1 shared paper, 2019 · strength 0.10
  7. Xiaomei Tang · 1 shared paper, 2019 · strength 0.10
  8. Shuyu Zhai · 1 shared paper, 2019 · strength 0.10
  9. Xiongxiong Lu · 1 shared paper, 2019 · strength 0.10
  10. Yuanbin Liu · 1 shared paper, 2019 · strength 0.10
  11. Xiaxing Deng · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.